Search   
MSDS  : Oxiraneheptanoic acid, 2-(3,5-dihydroxy-2,4-dimethylhexanoyl)-delta-((4-(dim ethylamino) tetrahydro-3-hydroxy-6-methylpyran-2-yl)oxy)-alpha,ga mma,epsilon-trimethyl -beta- ((tetrahydro-5-hydroxy-4-methoxy-6-methylpyran-2-yl)o xy), mu-lactone, hydrochloride
CAS  : 6696-47-5
SYNONYMS  : * Oleandomycin hydrochloride * Oleandomycin monohydrochloride
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : RR0500000
CHEMICAL NAME : Oxiraneheptanoic acid,
2-(3,5-dihydroxy-2,4-dimethylhexanoyl)-delta-((4-(dim
ethylamino)
tetrahydro-3-hydroxy-6-methylpyran-2-yl)oxy)-alpha,ga
mma,epsilon-trimethyl -beta-
((tetrahydro-5-hydroxy-4-methoxy-6-methylpyran-2-yl)o
xy), mu-lactone, hydrochloride
CAS REGISTRY NUMBER : 6696-47-5
LAST UPDATED : 199109
DATA ITEMS CITED : 6
MOLECULAR FORMULA : C35-H61-N-O12.Cl-H
MOLECULAR WEIGHT : 724.43
WISWESSER LINE NOTATION : T-14-VO GVXTJ C1 D1 EQ F1 J1 L1 N1 H-& BT3OX CHJ& KO-
BT6OTJ CQ DN1&1 F1& MO- FT6OTJ B1 CQ DO
COMPOUND DESCRIPTOR : Drug
Natural Product
SYNONYMS/TRADE NAMES :
* Oleandomycin hydrochloride
* Oleandomycin monohydrochloride

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 8,386,1958

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 8,386,1958

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 376 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC)
V.1-12, 1951-62. For publisher information, see CLMEA3.
Volume(issue)/page/year: 7,419,1957

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC)
V.1-12, 1951-62. For publisher information, see CLMEA3.
Volume(issue)/page/year: 7,419,1957

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 8,386,1958

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 460 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC)
V.1-12, 1951-62. For publisher information, see CLMEA3.
Volume(issue)/page/year: 7,419,1957

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Oxazolium, 2-(2-anilinovinyl)-3,4-dimethyl-, iodide 21034-17-3
Oxiranecarboxylic acid, 2,3-dimethyl-,2,3,3a,4,5,6,7,8,11,11a-decahydro-6,10-dimethyl-4-hydroxy-3-methylene-2,8-dioxocyclodeca(b)furan-5-ylester, (3ar- (3aR*,4R*,5R*(2R*,3R*),6R*,9Z,11aR*))- 103425-22-5
Oxiranecarboxylic acid,3-(((1-((4-(diphenylmethyl)-1-piperazinyl)carbonyl)-3-methylbutyl) amino)carbonyl)-, monosodium salt 84456-38-2
Oxiranecarboxylic acid,3-(((1-((4-ethyl-1-piperazinyl)carbonyl)-3-methylbutyl)amino) carbonyl)-, monosodium salt 84456-42-8
Oxiranecarboxylic acid,3-(((1-(((5-hydroxypentyl)amino)carbonyl)-3-methylbutyl)amino) carbonyl)-, dihydrate 160825-48-9
Oxiranecarboxylic acid,3-(((1-((4-((4-methoxyphenyl)methyl)-1-piperazinyl)carbonyl)-3- methylbutyl)amino)carbonyl)-, monosodiumsalt 84456-40-6
Oxiranecarboxylic acid,3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino) carbonyl)-, (2S-(2-alpha,3-beta(R*)))- 76684-89-4
Oxiranecarboxylic acid,3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino) carbonyl)-, ethyl ester,(2S-(2-alpha,3-beta(R*)))- 88321-09-9
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(phenylmethyl)-1-piperazinyl)carbonyl)butyl) amino)carbonyl)-, monosodium salt 84456-39-3
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(3-phenyl-2-propenyl)-1-piperazinyl)carbonyl) butyl)amino)carbonyl)-, monosodium salt 84456-43-9
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(2-pyridinyl)-1-piperazinyl)carbonyl)butyl) amino)carbonhyl)-, monosodium salt 84456-44-0
4H-Oxazolo(4,5-d)azepin-2-amine,5,6,7,8-tetrahydro-6-ethyl-, dihydrochloride 36067-72-8
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(2-pyrimidinyl)-1-piperazinyl)carbonyl)butyl) amino)carbonyl)-, monosodium salt 84456-45-1
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(2-pyrimidinyl)-1-piperazinyl)carbonyl)butyl) amino)carbonyl)-, monosodium salt,(2R-(2-alpha,3-beta(S*)))- 84518-85-4
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-(2-pyrimidinyl)-1-piperazinyl)carbonyl)butyl) amino)carbonyl)-, monosodium salt,(2S-(2-alpha,3-beta(R*)))- 84518-86-5
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-,monosodium salt 84456-41-7
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-, ethylester, (2R-(2-alpha,3-beta(S*)))-, sulfate (2:1) 84579-82-8
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-, ethylester, (2S-(2-alpha,3-beta(R*)))-, sulfate (2:1) 84579-83-9
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-,2-methylpropyl ester, sulfate (2:1) 84456-48-4
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-,monosodium salt, (2R-(2-alpha,3-beta(S*)))- 84518-83-2
Oxiranecarboxylic acid,3-(((3-methyl-1-((4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl) carbonyl)butyl)amino)carbonyl)-,monosodium salt, (2S-(2-alpha,3-beta(R*)))- 84518-84-3
Oxiranecarboxylic acid, 3-phenyl-,(1-(2-chlorophenyl)ethylidene)hydrazide 133662-11-0
Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one,10-chloro-11b-(o-chlorophenyl)-2,3,7,11b- tetrahydro- 24166-13-0
Oxiranecarboxylic acid, 3-phenyl-,((2-chlorophenyl)methylene)hydrazide 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester, (E)- 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester, (Z)- 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester,(2R,3R)-(-)- 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester,(2R,3S)-(-)- 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester,(2S,3R)-(+)- 133662-12-1
Oxiranecarboxylic acid, 3-phenyl-, methyl ester,(2S,3S)-(+)- 133662-12-1
2-Oxiranecarboxylic acid, 2-tetradecyl-, methyl ester 69207-52-9
Oxirane, (chloromethyl)-, (R)- 51594-55-9
Oxirane, (chloromethyl)-, (S)- 67843-74-7
Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one,10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyl- 31868-18-5
Oxirane, (chloromethyl)-, polymer withalpha-hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)) 9072-62-2
Oxirane, 2-(2-(4-chlorophenyl)ethyl)- 59363-17-6
Oxirane, 2-(p-chlorophenyl)-2-methyl- 59363-17-6
Oxirane, 2-((4-chlorophenyl)methyl)- 36519-91-2
Oxirane, 2-decyl-3-(5-methylhexyl)-, cis- 29804-22-6
2,2-Oxiranedicarboxamide, 3-benzoyl- 142438-70-8
Oxirane,2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)- 58138-08-2
Oxirane, ((1,1-dimethylethoxy)methyl)- 7665-72-7
Oxirane, 2,2-di-tert-pentyl- 64046-71-5
Oxirane, ((4-ethenylphenoxy)methyl)- 2653-39-6
Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one,10-chloro-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)- 27060-91-9
Oxirane, 2-((2-ethoxyphenyl)methyl)- 27060-91-9
Oxirane,3-(5-(4-ethylphenoxy)-3-methyl-3-pentenyl)-2,2-dimethyl-, (E)- 32766-80-6
Oxirane, 2-ethyl-3-phenyl-, cis- 69140-51-8
Oxirane, 2-ethyl-3-phenyl-, trans- 69140-50-7
Oxiraneheptanoic acid,2-(3,5-dihydroxy-2,4-dimethylhexanoyl)-delta-((4-(dimethylamino)tetrahydro-3-hydroxy-6-methylpyran-2-yl)oxy)-alpha,gamma,epsilon-trimethyl -beta-((tetrahydro-5-hydroxy-4-methoxy-6-methylpyran-2-yl)oxy), mu-lactone, hydrochloride 6696-47-5

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net